Anti-cytokine therapy for prevention of atherosclerosis

Tatiana V Kirichenko1, Igor A Sobenin2, Dragana Nikolic3

  • 1Institute for Atherosclerosis Research, Skolkovo Innovative Center, 4-1-207, Osennaya Str., 121609, Moscow, Russia.

Abstract

Insights

Chronic inflammation drives atherosclerosis. A novel herbal preparation, Inflaminat, demonstrated anti-atherosclerotic effects by reducing carotid intima-media thickness progression in a clinical study.

Area of Science:

  • Cardiovascular Research
  • Inflammation Biology
  • Pharmacology

Background:

  • Chronic inflammation is a key driver of atherosclerosis progression.
  • Extensive research has explored inflammatory mechanisms in atherosclerotic lesion development.

Purpose of the Study:

  • To review current anti-inflammatory therapies for atherosclerosis prevention and treatment.
  • To assess the efficacy of novel anti-cytokine herbal preparations.

Main Methods:

  • Systematic literature search on inflammatory cytokines and atherosclerosis.
  • Development and testing of an anti-inflammatory herbal preparation, Inflaminat.
  • A 2-year double-blind, placebo-controlled clinical trial evaluating Inflaminat's effect on carotid IMT progression.

Main Results:

  • Inflaminat, derived from Sambucus nigra, Viola tricolor, and Calendula officinalis, exhibited anti-cytokine activity.
  • The herbal preparation significantly reduced carotid intima-media thickness progression.
  • Inflaminat demonstrated a clear anti-atherosclerotic effect in the clinical study.

Conclusions:

  • Anti-cytokine therapy offers a promising approach for managing atherogenesis, particularly in early-stage subclinical atherosclerosis.
  • Herbal preparations with anti-cytokine mechanisms are highly promising for atherosclerosis prevention due to their safety profile and suitability for long-term use.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
578
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
563
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
547
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
737